mRNA vaccination with charge-altering releasable transporters elicits human T cell responses and cures established tumors in mice
暂无分享,去创建一个
R. Levy | R. Waymouth | P. Wender | O. Haabeth | Timothy R. Blake | C. McKinlay | R. Levy
[1] Daniel G. Anderson,et al. Optimization of Lipid Nanoparticle Formulations for mRNA Delivery in Vivo with Fractional Factorial and Definitive Screening Designs. , 2015, Nano letters.
[2] Khalid A. Hajj,et al. Tools for translation: non-viral materials for therapeutic mRNA delivery , 2017 .
[3] Ash A. Alizadeh,et al. Antigen Presentation Profiling Reveals Recognition of Lymphoma Immunoglobulin Neoantigens , 2017, Nature.
[4] Shubiao Zhang,et al. Toxicity of cationic lipids and cationic polymers in gene delivery. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[5] D. Munn,et al. Chemotherapy rescues tumor-driven aberrant CD4+ T-cell differentiation and restores an activated polyfunctional helper phenotype. , 2010, Blood.
[6] C. Melief,et al. Vaccines for established cancer: overcoming the challenges posed by immune evasion , 2016, Nature Reviews Cancer.
[7] C. Heirman,et al. The ReNAissanCe of mRNA-based cancer therapy , 2015, Expert review of vaccines.
[8] R. Coffman,et al. Vaccine adjuvants: putting innate immunity to work. , 2010, Immunity.
[9] Murali Ramamoorth,et al. Non viral vectors in gene therapy- an overview. , 2015, Journal of clinical and diagnostic research : JCDR.
[10] R. Zinkernagel,et al. In vivo antigen loading and activation of dendritic cells via a liposomal peptide vaccine mediates protective antiviral and anti-tumour immunity. , 2000, Vaccine.
[11] J. Utikal,et al. Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer , 2017, Nature.
[12] M. Tanimoto,et al. Identification of novel CTL epitopes of CMV-pp65 presented by a variety of HLA alleles. , 2004, Blood.
[13] Daniel G. Anderson,et al. Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and Toxoplasma gondii challenges with a single dose , 2016, Proceedings of the National Academy of Sciences.
[14] Özlem Türeci,et al. Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy , 2016, Nature.
[15] Kevin Welsher,et al. Deep-tissue anatomical imaging of mice using carbon nanotube fluorophores in the second near-infrared window , 2011, Proceedings of the National Academy of Sciences.
[16] Özlem Türeci,et al. mRNA-based therapeutics — developing a new class of drugs , 2014, Nature Reviews Drug Discovery.
[17] H. Blau,et al. Transient delivery of modified mRNA encoding TERT rapidly extends telomeres in human cells , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[18] D. Hoover,et al. Comparison of Protective Efficacy of Subcutaneous versus Intranasal Immunization of Mice with a Brucella melitensis Lipopolysaccharide Subunit Vaccine , 2006, Infection and Immunity.
[19] J. Pérez-Ortín,et al. Eukaryotic mRNA decay: methodologies, pathways, and links to other stages of gene expression. , 2013, Journal of molecular biology.
[20] M. Mirzakhani. The Work , 2020, Citadel.
[21] S. J. Payne,et al. Multi-emissive difluoroboron dibenzoylmethane polylactide exhibiting intense fluorescence and oxygen-sensitive room-temperature phosphorescence. , 2007, Journal of the American Chemical Society.
[22] Robert Langer,et al. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. , 2017, Nano letters.
[23] I. Verma,et al. Systemic delivery of factor IX messenger RNA for protein replacement therapy , 2017, Proceedings of the National Academy of Sciences.
[24] Michael R. Green,et al. Depleting tumor-specific Tregs at a single site eradicates disseminated tumors. , 2013, The Journal of clinical investigation.
[25] C. Contag,et al. Functional DNA Delivery Enabled by Lipid-Modified Charge-Altering Releasable Transporters (CARTs). , 2018, Biomacromolecules.
[26] Hao Zhu,et al. Non-Viral CRISPR/Cas Gene Editing In Vitro and In Vivo Enabled by Synthetic Nanoparticle Co-Delivery of Cas9 mRNA and sgRNA. , 2017, Angewandte Chemie.
[27] Robert Langer,et al. A combinatorial polymer library approach yields insight into nonviral gene delivery. , 2008, Accounts of chemical research.
[28] K. Kataoka,et al. Nanomaterial-Enabled Cancer Therapy. , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.
[29] Y. Kaneda,et al. RNA melanoma vaccine: induction of antitumor immunity by human glycoprotein 100 mRNA immunization. , 1999, Human gene therapy.
[30] R. Waymouth,et al. Enhanced mRNA delivery into lymphocytes enabled by lipid-varied libraries of charge-altering releasable transporters , 2018, Proceedings of the National Academy of Sciences.
[31] T. Wu,et al. Therapeutic HPV DNA vaccines , 2010, Immunologic research.
[32] T. Friedmann,et al. Gene Therapy for Human Genetic Disease? , 1972, Science.
[33] J. R. Vargas,et al. Charge-altering releasable transporters (CARTs) for the delivery and release of mRNA in living animals , 2017, Proceedings of the National Academy of Sciences.
[34] Gaurav Sahay,et al. Rapid discovery of potent siRNA-containing lipid nanoparticles enabled by controlled microfluidic formulation. , 2012, Journal of the American Chemical Society.
[35] G. Lenzen,et al. Induction of virus‐specific cytotoxic T lymphocytes in vivo by liposome‐entrapped mRNA , 1993, European journal of immunology.